E2814 - Eisai, University College London
JNJ-63733657 - J&J
tilavonemab (ABBV-8E12) - AbbVie
bepranemab (UCB0107) - UCB, Roche
semorinemab (RG6100) - Roche
gosuranemab (BIIB092) - Biogen
Lu AF87908 - Lundbeck
APNmAb005 - APRINOIA Therap
http://www.ncbi.nlm.nih.gov/pubmed/37620094
 
Antonio Daniele; Francesco Panza; Madia Lozupone; Vincenzo Solfrizzi
 
Aug 25, 2023
 
Next